• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018 - Product Image

High Throughput Screening (HTS) Market by Technology, Applications & by End Users - Forecast to 2018

  • Published: February 2014
  • 248 Pages
  • Markets and Markets

FEATURED COMPANIES

  • Aurora Biomed
  • Axxam Spa
  • Biofocus Dpi Ltd.
  • Bio-Rad Laboratories
  • Intellicyt Corporation
  • Luminex Corporation
  • MORE

'High Throughput Screening (HTS) Market by Technology (Cell Based, Ultra High Throughput Screening (uHTS), Label Free, Bioinformatics), by Apllications (Target Identification, Primary Screening, Toxicology, Stem Cell) & by End Users (Pharmaceutical Industry, Biotechnology Industry, CRO) - Forecast to 2018'

In this report, the global high throughput screening (HTS) market has been segmented on the basis of technology, products, applications, end users, and geography. The label-free technology market is expected to grow at the highest CAGR of 11.1% from 2013 to 2018. This technology offers the direct detection ability, which was not possible with cell-based assays. Moreover, this technology helps in the reduction of drug failure rate due to toxicity and is applicable for a majority of drug classes.

In the HTS applications market, the target identification segment accounted for the largest share in 2013. The large share of this segment can be attributed to factors such as the availability of large compound libraries, presence of well-equipped HTS laboratories, and technological advancements. Large pharmaceutical and biotechnology companies are investing heavily in automation READ MORE >

1 Introduction
1.1 Objectives Of The Study
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Market Scope
1.6 Research Methodology
1.6.1 Secondary Sources
1.6.2 Primary Sources
1.6.3 Market Size Estimation
1.6.4 Market Share
1.6.5 Key Data Points From Secondary Sources
1.6.6 Key Data Points From Primary Sources
1.6.7 Assumptions

2 Executive Summary

3 Premium Insights
3.1 Hts Market - A Sub-Segment Of Drug Discovery Market
3.2 Global Hts Market
3.3 Market Dynamics
3.4 Geographic Analysis & Hts Technologies Market
3.5 Technology Market
3.6 End-User Analysis
3.7 Competitive Analysis

4 Market Overview
4.1 Introduction
4.2 Technology Evolution
4.3 Market Segmentation
4.4 Market Dynamics
4.4.1 Drivers
4.4.1.1 Adoption Of Open Innovation Models By Pharmaceutical Companies To Increase The Use Of Hts
4.4.1.2 Increasing Drug Discovery Initiatives By Academic And Government Institutions To Boost The Demand For Hts Products
4.4.1.3 Increasing Capital Investments In Hts Technology By Organizations Lead To The Growth Of Hts
4.4.1.4 Technological Advancements In Research Leading To Large Potential Candidates For Screening Will Help Hts
4.4.1.5 Increase In The Number Of Outsourced Drug Discovery Services Will Propel The Hts Market
4.4.2 Restraints
4.4.2.1 The Capital-Intensive Nature Of Hts Will Hamper The Growth Of This Market
4.4.2.2 Assay Development For Hts Becoming Difficult For New Target Classes
4.4.3 Opportunities
4.4.3.1 Growing Asian Market To Boost The Hts Market
4.4.3.2 High Throughput Cellular Microarrays Increasingly Being Used In Toxicology And Stem Cell Research, Thus Prompting Its Growth
4.4.3.3 Growth Of Contract Research Organizations (Cros) In Emerging Countries To Bolster The Hts Market
4.4.3.4 Label-Free Technology Emerging As A Valuable Tool For Drug Discovery
4.5 Trends
4.5.1 Label-Free Method Gaining Importance In Hts Labs
4.5.2 Hts Techniques Increasingly Being Used In The Field Of Toxicology
4.5.3 Automation & Miniaturization Of Hts Techniques
4.6 Strategic Benchmarking
4.6.1 New Product Launches
4.6.1.1 Agilent Technologies Introduced The Rapidfire 365 High Throughput Mass Spectrometry System
4.6.1.2 Perkinelmer Introduced The Janus Biotx Pro Automated Workstation
4.6.1.3 Beckman Coulter Introduced The Navios Flow Cytometry System
4.6.1.4 Sigma-Aldrich Introduced The Compozr Transporter Knockout Human Cell Lines In Plate Format
4.6.1.5 Tecan Group Introduced Dako Omnis
4.6.2 Technology Integration
4.6.2.1 Collaboration Between Agilent & Baylor College Of Medicine's Medical Genetics Laboratories
4.6.2.2 Collaboration Between Perkinelmer & The National Center For Drug Screening (Ncds)
4.6.2.3 Partnership Of Beckman Coulter With Illumina
4.6.2.4 Agreement Of Sigma-Aldrich Corporation With Alphagenix
4.6.2.5 Agreement Of Tecan Group With Tap Biosystems
4.7 Value Chain Analysis
4.8 Porter'S Five Forces Analysis
4.8.1 Threat From New Entrants
4.8.2 Threat From Substitutes
4.8.3 Bargaining Power Of Buyers
4.8.4 Bargaining Power Of Suppliers
4.8.5 Competitive Rivalry Among Existing Players
4.9 Key Player Analysis

5 High Throughput Screening Market, By Technology
5.1 Introduction
5.2 Cell-Based Assays
5.2.1 Cell-Based Assays Are Used In More Than 50% Of Hts Assays
5.3 Ultra High Throughput Screening (Uhts)
5.3.1 Uhts Increasers The Number Of Potential Drug Candidates Tested Per Day
5.4 Lab-On-A-Chip (Loac)
5.4.1 Loac Market To Grow At A High Pace
5.5 Label-Free Technology
5.5.1 Label-Free Technology To Grow At The Fastest Pace In Hts Market
5.6 Bioinformatics
5.6.1 Bioinformatics Reduces The Cost And Duration Of Drug Discovery Process

6 High Throughput Screening Market, By Product
6.1 Introduction
6.2 Instruments
6.2.1 The Demand For Automated And Easy-To-Use Systems On A Rise
6.3 Consumables/Reagents
6.3.1 Assay Kits To Drive The Hts Market
6.4 Software & Services
6.4.1 Outsourcing To Drive The Hts Services Market

7 Global High Throughput Screening Market, By Application
7.1 Introduction
7.2 Target Identification
7.2.1 Target Identification Segment Occupies The Largest Share Of Hts Applications Market
7.3 Primary Screening
7.3.1 Primary Screening Is The Second Largest Hts Applications Market
7.4 Toxicology
7.4.1 Recent Advancements Present Significant Opportunities For Toxicity Testing
7.5 Stem Cell Biology
7.5.1 Stem Cells Provide Significant Advantages To Hts Technology
7.6 Other Applications

8 Global High Throughput Screening Market, By End Users
8.1 Introduction
8.2 Pharmaceutical & Biotechnology Industry
8.2.1 Pharmaceutical Companies Are The Biggest End-Users For Hts
8.3 Academic & Government Institutes
8.3.1 Open Innovation To Drive The Hts Market In Government Sector
8.4 Contract Research Organizations (Cro)
8.4.1 Emerging Countries To Drive The Hts Market For Cro
8.5 Other Industries (Hospitals/Clinics, Agriculture, Environmental Labs)

9 Geographic Analysis
9.1 Introduction
9.2 North America
9.2.1 Rising Investments By Drug Discovery Companies To Drive The North American Hts Market
9.2.2 Collaborations Between Companies And Academic Institutes On A Rise
9.3 Europe
9.3.1 Public-Private Partnerships To Goad The European Hts Market
9.4 Asia
9.4.1 Government Initiatives Provide Scope For Growth Of Hts Market In Asia
9.5 Rest Of The World (Row)

10 Competitive Landscape
10.1 Introduction
10.1.1 New Product Launch, The Key Growth Strategy Adopted By Hts Players
10.1.2 New Product Launch
10.1.3 Agreements, Partnerships, And Collaborations
10.1.4 Mergers & Acquisitions
10.1.5 Expansions
10.1.6 Other Developments

11 Company Profiles
(Overview, Financials, Products & Services, Strategy, & Developments)*
11.1 Agilent Technologies, Inc.
11.2 Aurora Biomed
11.3 Axxam Spa
11.4 Beckman Coulter, Inc. (A Subsidiary Of Danaher)
11.5 Bio-Rad Laboratories
11.6 Biofocus Dpi Ltd.
11.7 Intellicyt Corporation
11.8 Luminex Corporation
11.9 Perkinelmer, Inc.
11.1 Sigma Aldrich Corporation
11.11 Tecan Group Ltd.
11.12 Thermo Fisher Scientific, Inc.
*Details On Financials, Product & Services, Strategy, & Developments Might Not Be Captured In Case Of Unlisted Companies.
Appendix

List Of Tables

Table 1 Global Eclinical Solutions Market, By Type, 2011–2018 ($Million)
Table 2 Eclinical Solutions Market, By Product, 2011–2018 ($Million)
Table 3 Eclinical Solution Products Market, By Geography, 2011–2018 ($Million)
Table 4 Cdms/Edc Solutions Market, By Geography, 2011–2018 ($Million)
Table 5 Ctms Solutions Market, By Geography, 2011–2018 ($Million)
Table 6 Ecoa Solutions Market, By Geography, 2011–2018 ($Million)
Table 7 Rtsm Systems Market, By Geography, 2011–2018 ($Million)
Table 8 Safety Solutions Market, By Geography, 2011–2018 ($Million)
Table 9 Other Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 10 Global Eclinical Solutions Market, By Professional Services, 2011–2018 ($Million)
Table 11 Global Eclinical Solutions Professional Services Market, By Geography, 2013–2018 ($Million)
Table 12 Implementation Services Market, By Geography, 2013–2018 ($Million)
Table 13 Training Services Market, By Geography, 2013–2018 ($Million)
Table 14 Support Services Market, By Geography, 2013–2018 ($Million)
Table 15 Consulting Services Market, By Geography, 2013–2018 ($Million)
Table 16 Global Eclinical Solutions Market, By Type Of Buyer, 2011–2018 ($Million)
Table 17 Pharmaceutical/Biopharmaceutical/Medical Device Companies Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 18 Cros Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 19 Healthcare Providers Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 20 Eclinical Solutions Market, By Delivery Mode, 2011–2018 ($Million)
Table 21 Web-Based Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 22 On-Premise Model Based Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 23 Cloud-Based Eclinical Solutions Market, By Geography, 2011–2018 ($Million)
Table 24 Global Eclinical Solutions Market, By Geography, 2013–2018 ($Million)
Table 25 North America: Eclinical Solutions Market, By Products And Services, 2013–2018 ($Million)
Table 26 North America: Eclinical Solutions Market, By Product, 2013–2018 ($Million)
Table 27 North America: Eclinical Solutions Market, By Professional Service, 2013–2018 ($Million)
Table 28 North America: Eclinical Solutions Market, By Type Of Buyer, 2013–2018 ($Million)
Table 29 North America: Eclinical Solutions Market, By Delivery Mode, 2013–2018 ($Million)
Table 30 Europe: Eclinical Solutions Market, By Products And Services, 2013–2018 ($Million)
Table 31 Europe: Eclinical Solutions Market, By Product, 2013–2018 ($Million)
Table 32 Europe: Eclinical Solutions Market, By Professional Service, 2013–2018 ($Million)
Table 33 Europe: Eclinical Solutions Market, By Type Of Buyer, 2013–2018 ($Million)
Table 34 Europe: Eclinical Solutions Market, By Delivery Mode, 2013–2018 ($Million)
Table 35 Asia-Pacific: Eclinical Solutions Market, By Products And Services, 2013–2018 ($Million)
Table 36 Asia-Pacific: Eclinical Solutions Market, By Product, 2013–2018 ($Million)
Table 37 Asia-Pacific: Eclinical Solutions Market, By Professional Services, 2013–2018 ($Million)
Table 38 Asia-Pacific: Eclinical Solutions Market, By Type Of Buyer, 2013–2018 ($Million)
Table 39 Asia-Pacific: Eclinical Solutions Market, By Delivery Mode, 2013–2018 ($Million)
Table 40 Row: Eclinical Solutions Market, By Products And Services, 2013–2018 ($Million)
Table 41 Row: Eclinical Solutions Market, By Product, 2013–2018 ($Million)
Table 42 Row: Eclinical Solutions Market, By Professional Service, 2013–2018 ($Million)
Table 43 Row: Eclinical Solutions Market, By Type Of Buyer, 2013–2018 ($Million)
Table 44 Row: Eclinical Solutions Market, By Delivery Mode, 2013–2018 ($Million)
Table 45 Agreements, Partnerships, Collaborations, And Joint Ventures, 2011–2013
Table 46 New Product Launch And Product Development, 2011–2013
Table 47 Mergers & Acquisitions, 2011–2013
Table 48 Other Developments, 2011–2013
Table 49 Bioclinica, Inc.: Total Revenue, 2010–2012 ($Million)
Table 50 Datatrak International, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 51 Eresearch Technology, Inc.: Total Revenue And R&D Expenditure, 2009 – 2011 ($Million)
Table 52 Medidata Solutions, Inc.: Total Revenue, 2010 – 2012 ($Million)
Table 53 Merge Healthcare, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 54 Omnicomm Systems, Inc.: Total Revenue And R&D Expenditure, 2010–2012 ($Million)
Table 55 Oracle Corporation: Total Revenue And R&D Expenditure, 2011–2013 ($Million)
Table 56 Parexel International Corp.: Total Revenue And R&D Expenditure, 2011 – 2013 ($Million)

List Of Figures

Figure 1 Global Eclinical Solutions Market: Research Methodology
Figure 2 Market Size Estimation Methodology
Figure 3 Global Eclinical Solutions Market, By Segments, 2013
Figure 4 Global Eclinical Solutions Market, By Geography, 2013
Figure 5 Clinical Trial Process
Figure 6 Benefits Of Using Eclinical Solutions In Clinical Trials
Figure 7 Eclinical Solutions Market Segmentation
Figure 8 Eclinical Solutions Market Segmentation, By Product
Figure 9 Eclinical Solutions Market Segmentation, By Service
Figure 10 Eclinical Solutions Market Segmentation, By Type Of Buyer
Figure 11 Eclinical Solutions Market Segmentation, By Delivery Mode
Figure 12 Market Dynamics: Global Eclinical Solutions Market
Figure 13 Impact Analysis: Drivers Of The Eclinical Solutions Market
Figure 14 Impact Analysis: Restraints Of The Eclinical Solutions Market
Figure 15 Global Eclinical Solutions Market, By Product, 2013 Vs. 2018
Figure 16 Benefits Of Edc System Applications In Clinical Trials
Figure 17 Ctms Modules
Figure 18 Global Eclinical Solutions Market, By Professional Services, 2013 Vs. 2018
Figure 19 Global Eclinical Solutions Market, By Type Of Buyer, 2013 Vs. 2018
Figure 20 Global Eclinical Solutions Market, By Delivery Mode, 2013 Vs. 2018
Figure 21 Global Eclinical Solutions Market, By Geography, 2013–2018 ($Million)
Figure 22 Global Cdms/Edc Solutions Market Share, By Key Players, 2012
Figure 23 Global Ctms Solutions Market Share, By Key Players, 2012
Figure 24 Global Ecoa Solutions Market, By Key Players, 2012
Figure 25 Key Growth Strategies, 2011–2013
Figure 26 Bioclinica, Inc.: Business Revenue Mix, 2012
Figure 27 Bioclinica, Inc.: Service Segment, Geographic Revenue Mix, 2012
Figure 28 Bioclinica, Inc.: Major Strategy, 2011–2013
Figure 29 Crf Health: Major Strategy, 2011–2013
Figure 30 Datatrak International, Inc.: Major Strategy, 2011–2013
Figure 31 Eresearch Technology, Inc.: Business Revenue Mix, 2011
Figure 32 Eresearch Technology, Inc.: Geographic Revenue Mix, 2011
Figure 33 Eresearch Technology, Inc.: Major Strategy, 2011–2013
Figure 34 Medidata Solutions, Inc.: Business Revenue Mix, 2012
Figure 35 Medidata Solutions, Inc.: Geographic Revenue Mix, 2012
Figure 36 Medidata Solutions, Inc.: Major Strategy, 2011–2013
Figure 37 Merge Healthcare, Inc.: Business Revenue Mix, 2012
Figure 38 Merge Healthcare, Inc.: Geographic Revenue Mix, 2012
Figure 39 Merge Healthcare, Inc.: Major Strategy, 2011–2013
Figure 40 Omnicomm Systems, Inc.: Business Revenue Mix, 2012
Figure 41 Omnicomm Systems, Inc.: Major Strategy, 2011–2013
Figure 42 Oracle Corporation: Business Revenue Mix, 2013
Figure 43 Oracle Corporation: Geographic Revenue Mix, 2013
Figure 44 Oracle Corporation: Major Strategy, 2011–2013
Figure 45 Parexel International Corp.: Business Revenue Mix, 2013
Figure 46 Parexel International Corp.: Geographic Revenue Mix, 2013
Figure 47 Parexel International Corporation: Major Strategy, 2011–2013
Figure 48 Pht Corporation: Major Strategy, 2011–2013

In recent years, the high throughput screening (HTS) market has witnessed a large number of technological advancements, which has resulted in an increase in the rate of adoption of HTS in laboratories. The global HTS market was valued at $13,736 million in 2013 and is expected to reach $19,627 million by 2018, at a CAGR of 7.4%. The HTS market is broadly classified into five segments, namely, technologies, products, applications, end users, and geography.

The technology market is sub-divided into ultra high throughput screening, cell-based assays, lab-on-a chip, label-free technology, and bioinformatics. The cell-based assays segment dominated the HTS market in 2013, followed by the lab-on-a-chip segment. The HTS products market is broadly categorized into instruments, consumables/reagents, and software and services. The consumables/reagents segment dominated this market in 2013, with a market share of around 57%. The applications market is segmented into target identification, primary screening, toxicology, stem cell biology, and others. Target identification dominated the HTS applications market in 2013, followed by the primary screening market. The HTS market by end user is broadly categorized into pharmaceutical companies, biotechnology companies, academic and government institutes, contract research organizations (CROs), and others. The pharmaceuticals segment dominated the market in 2013, with a market share of around 48%.

The major factors driving the growth of the HTS market are technological innovations, open innovation models adopted by pharmaceutical companies, increasing drug discovery initiatives by academic institutions, and huge capital investments in HTS technology by organizations. Moreover, the presence of a large untapped market in emerging countries and growth in outsourcing of drug discovery services especially in China and India are the various factors that are expected to provide growth opportunities for players in this market. However, the capital intensive nature of HTS and difficulties in assay development for novel target classes are the factors curbing the growth of this market.

The global HTS market is dominated by North America, followed by Europe. North America will continue to lead the global HTS market in the forecast period. Over the next five years, Asia is expected to grow at the highest CAGR of 9.1%. Factors such as growth in investments as well as the growth in the outsourcing industry, and favorable economic conditions are responsible for the high growth of the HTS market in Asia.

The major players in the HTS market include Agilent Technologies (U.S.), PerkinElmer (U.S.), Beckman Coulter, Inc. (a subsidiary of Danaher Corporation) (U.S.), Sigma-Aldrich Corporation (U.S.), and Tecan Group (Switzerland), among others.

- Agilent Technologies, Inc.
- Aurora Biomed
- Axxam Spa
- Beckman Coulter, Inc. (A Subsidiary Of Danaher)
- Bio-Rad Laboratories
- Biofocus Dpi Ltd.
- Intellicyt Corporation
- Luminex Corporation
- Perkinelmer, Inc.
- Sigma Aldrich Corporation
- Tecan Group Ltd.
- Thermo Fisher Scientific, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos